Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp

IART

Market Cap$1.3B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Integra Lifesciences Holdings CorpIntegra Lifesciences Holdings Corp-186.9-0%0.61.3
$25.47

Current Fair Value

97.6% upside

Undervalued by 97.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.30 Billion
Enterprise Value$3.05 Billion
Dividend Yield$0 (0%)
Earnings per Share$-0.09
Beta1.25
Outstanding Shares77,010,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-186.9
PEG9290.46
Price to Sales0.64
Price to Book Ratio0.64
Enterprise Value to Revenue1.89
Enterprise Value to EBIT114.19
Enterprise Value to Net Income-440
Total Debt to Enterprise0.65
Debt to Equity1.29

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Integra Lifesciences Holdings Corp

CEO: Peter Arduini